MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Movement disorders as a manifestation of aceruloplasminemia a case report

    A. Camargo (Bogota, Colombia)

    Objective: To develop a step-by-step diagnostic approach to aceruloplasminemia with initial presentation of movement disorders Background: Aceruloplasminemia is a rare iron overload disorder with autosomal…
  • 2025 International Congress

    The Impact of Non-Motor Symptoms on Quality of Life in Early Parkinson’s Disease: A Prospective Study

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To assess the prevalence and severity of non-motor symptoms (NMS) in early Parkinson’s disease (PD) and their impact on health-related quality of life (HRQoL).…
  • 2025 International Congress

    Quantitative evaluation of speech characteristics in Assessment of Motor Speech for Dysarthria (AMSD) using acoustic analysis

    R. Kotani, Y. Shirota, A. Seto, Y. Nagashima, H. Onodera, K. Yatani, M. Hamada, T. Toda (Tokyo, Japan)

    Objective: This study aims to extract acoustic features from speech data obtained from patients undergoing the Assessment of Motor Speech for Dysarthria (AMSD), a clinical…
  • 2025 International Congress

    Empathy in Action A Sensory Experience for Healthcare Providers

    K. Papesh, A. Mitchell, C. Pizzillo (Phoenix, USA)

    Objective: Evaluate the impact of a multisensory, hands-on experience designed to simulate the motor and non-motor symptoms of Parkinson’s disease (PD) on healthcare providers’ (HCPs)…
  • 2025 International Congress

    Phenotypic Variability Across Four Generations in a Family with CACNA1A Mutation

    R. Usman, M. Moreno Escobar (Morgantown, USA)

    Objective: Our objective is to describe phenotypic variability across four generations in a family with a specific CACNA1A mutation. Background: CACNA1A is a gene located…
  • 2025 International Congress

    A Clinical Overlap Presentation of Episodic Ataxia Type 2 and Periodic Paralysis with a Novel Mutation in CACNA1A

    C. Vila, K. Minks, P. Morrison (Rochester, USA)

    Objective: To describe a case of episodic ataxia type 2 (EA2) with features of periodic paralysis (PP) associated with a novel mutation in CACNA1A. Background:…
  • 2025 International Congress

    Role and Integration of a Dietitian into the Deep Brain Stimulation Multidisciplinary Screening Process

    T. Mehta, P. Graese, A. Barnes, E. Truscott, C. Hess, M. Okun (Gainesville, USA)

    Objective: Define the role and integration of a dietitian into the multidisciplinary screening process for deep brain stimulation (DBS) in movement disorders. Background: Most DBS…
  • 2025 International Congress

    Acceptability, Feasibility, and Appropriateness of wearable technology in Lewy body dementia

    B. Patel, S. Staras, T. Manini, M. Armstrong (Gainesville, USA)

    Objective: Determine implementation outcomes of Apple watches amongst individuals with Lewy body dementia (LBD) and their care partners. Background: Wearable technology can provide valuable information about…
  • 2025 International Congress

    Identification of Cerebrotendinous Xanthomatosis in Patients with Neurodegenerative Disorders from the Cincinnati Cohort Biomarker Program

    L. Marsili, M. Kauffman, K. Duque, J. Abanto, R. Dutta, T. Pramparo, J. Terner-Rosenthal, A. Espay (Cincinnati, USA)

    Objective: To develop an algorithm for identifying patients with cerebrotendinous xanthomatosis (CTX) in a cohort of individuals with neurodegenerative disorders. Background: CTX is a rare…
  • 2025 International Congress

    Neurological manifestations and genotypes of Gaucher disease type 3: MDSGene systematic review

    S. Schaake, T. Usnich, J. Boehm, N. Steffen, N. Schell, C. Krüger, T. Gül-Demirkale, N. Bahr, T. Kleinz, H. Madoev, B. Laabs, Z. Gan-Or, R. Alcalay, C. Marras, K. Lohmann, C. Klein, M. Rossi (Luebeck, Germany)

    Objective: To characterize the spectrum of neurological manifestations of Gaucher disease type 3 (GD3) and identify the most common GBA1 variants. Background: Gaucher disease is…
  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley